Business Context and Reporting Period
This Form 8-K Current Report was filed by LifeStance Health Group, Inc. on July 2, 2026. The filing addresses corporate governance changes, specifically the departure of a director and the appointment of three new directors to the Board.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters under Item 5.02.
Material Changes
- Director Resignation: Jeffrey Rhodes resigned from the Board and all committees effective immediately on July 2, 2026. The resignation was not due to any disagreement with the Company.
- New Director Appointments: The Board appointed three new directors to fill vacancies:
- Thurman Justice: Appointed as a Class II director (serving until the 2029 annual meeting). He will serve on the Audit Committee and the Quality and Compliance Committee.
- Lori Goltermann: Appointed as a Class II director (serving until the 2029 annual meeting). She will serve on the Compensation Committee and the Nominating and Governance Committee.
- Safwan Shabab: Appointed as a Class III director (serving until the 2027 annual meeting) pursuant to a Stockholder's Agreement dated June 9, 2021. He will serve on the Nominating and Governance Committee.
- Compensatory Arrangements: Mr. Justice and Ms. Goltermann each received an initial award of 35,492 restricted stock units (RSUs) under the Company's 2021 Equity Incentive Plan. These awards are subject to time-and performance-based vesting and continued service on the Board.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, or specific risk factors beyond the standard disclosure of the director changes.
Investor Verification Checklist
- Verify the specific terms of the time-and performance-based vesting for the 35,492 RSUs awarded to Thurman Justice and Lori Goltermann.
- Review the Stockholder's Agreement dated June 9, 2021 (Exhibit 10.2 to the June 15, 2021 8-K) to understand the rights and obligations associated with Safwan Shabab's appointment.
- Confirm the composition of the Board committees following these appointments to ensure quorum and independence requirements are met.